tiprankstipranks
Conmed (DE:EC8)
FRANKFURT:EC8
Germany Market
EC8
Conmed
RESEARCH TOOLSreports

Conmed (EC8) Ratios

3 Followers

Conmed Ratios

DE:EC8's free cash flow for Q2 2026 was $0.57. For the 2026 fiscal year, DE:EC8's free cash flow was decreased by $ and operating cash flow was $0.11. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.48 2.14 2.30 1.98 1.96
Quick Ratio
 0.69 1.01 1.05 0.96 0.84
Cash Ratio
 0.08 0.13 0.09 0.08 0.10
Solvency Ratio
 0.10 0.08 0.15 0.09 -0.02
Operating Cash Flow Ratio
 0.33 0.54 0.60 0.40 0.11
Short-Term Operating Cash Flow Coverage
 0.85 239.73 233.52 0.00 0.48
Net Current Asset Value
$ -583.25M$ -619.79M$ -703.56M$ -850.15M$ -970.82M
Leverage Ratios
Debt-to-Assets Ratio
 0.36 0.36 0.39 0.43 0.46
Debt-to-Equity Ratio
 0.80 0.81 0.94 1.19 1.41
Debt-to-Capital Ratio
 0.44 0.45 0.48 0.54 0.59
Long-Term Debt-to-Capital Ratio
 0.39 0.45 0.48 0.54 0.57
Financial Leverage Ratio
 2.21 2.25 2.40 2.76 3.08
Debt Service Coverage Ratio
 0.74 4.10 6.36 4.43 -0.02
Interest Coverage Ratio
 4.95 4.54 5.37 3.03 2.42
Debt to Market Cap
 0.56 0.66 0.43 0.29 0.40
Interest Debt Per Share
 28.74 27.90 30.57 33.62 36.08
Net Debt to EBITDA
 4.43 5.14 3.24 5.02 131.56
Profitability Margins
Gross Profit Margin
54.80%52.77%56.08%54.33%54.64%
EBIT Margin
8.24%7.44%15.33%9.69%-4.01%
EBITDA Margin
13.11%11.24%20.82%15.46%0.75%
Operating Profit Margin
10.79%10.27%15.33%9.69%6.70%
Pretax Profit Margin
6.06%5.17%12.47%6.49%-6.78%
Net Profit Margin
4.12%3.42%10.13%5.18%-7.71%
Continuous Operations Profit Margin
4.12%3.42%10.13%5.18%-7.71%
Net Income Per EBT
67.88%66.17%81.23%79.75%113.72%
EBT Per EBIT
56.20%50.39%81.38%67.02%-101.15%
Return on Assets (ROA)
2.46%2.02%5.74%2.80%-3.51%
Return on Equity (ROE)
5.51%4.55%13.76%7.73%-10.81%
Return on Capital Employed (ROCE)
8.03%7.02%9.88%6.06%3.50%
Return on Invested Capital (ROIC)
4.97%4.64%8.02%4.81%3.38%
Return on Tangible Assets
6.02%5.02%14.99%7.64%-10.07%
Earnings Yield
3.81%3.73%6.27%1.92%-3.03%
Efficiency Ratios
Receivables Turnover
 5.72 5.55 5.50 5.14 5.46
Payables Turnover
 6.14 6.93 5.61 6.44 6.46
Inventory Turnover
 1.72 1.83 1.66 1.79 1.43
Fixed Asset Turnover
 12.46 12.13 11.29 10.31 9.04
Asset Turnover
 0.60 0.59 0.57 0.54 0.46
Working Capital Turnover Ratio
 4.59 3.82 3.92 4.22 3.81
Cash Conversion Cycle
 216.23 213.08 221.85 218.78 266.09
Days of Sales Outstanding
 63.76 65.81 66.39 71.04 66.80
Days of Inventory Outstanding
 211.91 199.92 220.48 204.38 255.78
Days of Payables Outstanding
 59.43 52.66 65.02 56.64 56.49
Operating Cycle
 275.67 265.73 286.87 275.42 322.58
Cash Flow Ratios
Operating Cash Flow Per Share
 5.01 5.50 5.41 4.09 1.11
Free Cash Flow Per Share
 4.47 4.86 4.99 3.47 0.39
CapEx Per Share
 0.54 0.64 0.42 0.62 0.73
Free Cash Flow to Operating Cash Flow
 0.89 0.88 0.92 0.85 0.35
Dividend Paid and CapEx Coverage Ratio
 5.28 3.83 4.42 2.88 0.73
Capital Expenditure Coverage Ratio
 9.34 8.62 12.76 6.59 1.53
Operating Cash Flow Coverage Ratio
 0.18 0.20 0.18 0.13 0.03
Operating Cash Flow to Sales Ratio
 0.11 0.12 0.13 0.10 0.03
Free Cash Flow Yield
9.10%11.97%7.29%3.17%0.43%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 26.62 26.71 15.94 52.10 -33.04
Price-to-Sales (P/S) Ratio
 1.08 0.92 1.62 2.70 2.55
Price-to-Book (P/B) Ratio
 1.42 1.22 2.19 4.03 3.57
Price-to-Free Cash Flow (P/FCF) Ratio
 10.99 8.35 13.72 31.59 229.94
Price-to-Operating Cash Flow Ratio
 9.85 7.38 12.64 26.79 79.81
Price-to-Earnings Growth (PEG) Ratio
 -0.55 -0.41 0.15 -0.29 0.15
Price-to-Fair Value
 1.42 1.22 2.19 4.03 3.57
Enterprise Value Multiple
 12.63 13.29 10.99 22.47 473.02
Enterprise Value
 2.27B 2.05B 2.99B 4.33B 3.69B
EV to EBITDA
 12.63 13.29 10.99 22.47 473.02
EV to Sales
 1.66 1.49 2.29 3.47 3.53
EV to Free Cash Flow
 16.91 13.61 19.45 40.68 318.53
EV to Operating Cash Flow
 15.10 12.03 17.92 34.51 110.55
Tangible Book Value Per Share
 -10.64 -11.47 -14.92 -20.29 -25.02
Shareholders’ Equity Per Share
 34.63 33.29 31.21 27.20 24.82
Tax and Other Ratios
Effective Tax Rate
 0.32 0.34 0.19 0.20 -0.14
Revenue Per Share
 45.65 44.29 42.37 40.59 34.80
Net Income Per Share
 1.88 1.52 4.29 2.10 -2.68
Tax Burden
 0.68 0.66 0.81 0.80 1.14
Interest Burden
 0.74 0.70 0.81 0.67 1.69
Research & Development to Revenue
 0.04 0.04 0.04 0.04 0.05
SG&A to Revenue
 0.40 0.38 0.37 0.00 0.00
Stock-Based Compensation to Revenue
 0.01 0.02 0.02 0.02 0.02
Income Quality
 2.67 3.63 1.26 1.94 -0.41
Currency in USD